N

NovoCure Limited
D

NVCR

17.385
USD
0.29
(1.67%)
Market Open
Volume
1,401
EPS
-1
Div Yield
-
P/E
-13
Market Cap
1,887,033,009
Related Instruments
    AAPL
    AAPL
    -3.130
    (-1.37%)
    229.23 USD
    AMZN
    AMZN
    -8.930
    (-4.22%)
    197.48 USD
    GOOGL
    GOOGL
    -3.110
    (-1.77%)
    164.54 USD
    I
    ICUI
    -4.120
    (-2.40%)
    167.760 USD
    IDXX
    IDXX
    -2.54
    (-0.60%)
    421.30 USD
    ISRG
    ISRG
    -10.30
    (-1.92%)
    542.5 USD
    M
    MMSI
    0.620
    (0.61%)
    101.870 USD
    TSLA
    TSLA
    9.69
    (3.11%)
    352.925 USD
    More
News

Title: NovoCure Limited

Sector: Healthcare
Industry: Medical Devices
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatmentof solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derivesmajority of its revenue from the United States and rest from Germany, Japan and other markets.